Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714697
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-01-19
First Post:
2021-01-07
Brief Title:
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Organization Data
Organization:
Asan Medical Center
Class:
OTHER
Study ID:
AT ASIA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Asan Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Jae-Lyun Lee
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Asan Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ipsen | INDUSTRY |